CV Sciences, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value
CV Sciences, Inc. (CVSI) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value of $0 for the 12-month period ending 2021-12-31, per its 10-K filed 2023-03-30.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue · last filed 2023-03-30
- CV Sciences, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2019-03-31 was $3.30M.
- CV Sciences, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
- CV Sciences, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2020 was $100.00K, a 97.67% decline from fiscal 2019.
- CV Sciences, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2019 was $4.30M, a 27.12% decline from fiscal 2018.
- CV Sciences, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2018 was $5.90M.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 12 month as first filed |
|---|---|---|---|
| 2021-12-31 | $0.00 10-K · filed 2023-03-30 | ||
| 2020-12-31 | $100.00K 10-K · filed 2022-04-04 | ||
| 2019-12-31 | $4.30M 10-K · filed 2021-03-19 | ||
| 2019-03-31 | $3.30M 10-Q · filed 2019-05-09 | ||
| 2018-12-31 | $5.90M 10-K · filed 2020-03-30 | $5.90M 10-K · filed 2019-03-12 |